Trends & Forecasts

The Ebola media frenzy has reminded the public how selfish our industry is. But, somehow, that doesn’t sound quite right...

Organizations all over the globe are taking action against drug resistance.

Patients and physicians are tweeting, snapchatting, pinning and posting about healthcare, – some are making the leap into the digital world.

In a world of regulatory rigor and complex supply chains, product recalls are becoming increasingly challenging.

Hiring gifted new employees is tough enough, but how do you keep them within your organization once you’ve got them?

Mysterious cyber attackers are hitting pharma manufacturing systems

New Alzheimer’s treatment gets $500 million collaborative boost

Opportunistic investors surf the wave of experimental treatments

Merck KGaA snaps up Sigma-Aldrich, Allergan fights Valeant, and Shire–Abbvie deal sours

“Welcome to Big Pharma, where you can make a fortune and still maintain a healthy conscience. Or can you?”